NCT06834282
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06834282
Title CER-1236 in Patients With Acute Myeloid Leukemia (AML) (CertainT-1)
Acronym CertainT-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors CERo Therapeutics Holdings, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Colorado Blood Cancer Institute RECRUITING Denver Colorado 80218 United States Details
Sarah Cannon Research Insitute RECRUITING Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field